Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

Caribou Biosciences ( ($CRBU) ) has provided an update. On November 3, 2025, Caribou Biosciences announced positive results from its ANTLER phase ...

Trichomes—the tiny hair-like structures covering tomato surfaces—serve as a crucial frontline defense against environmental ...

The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...

T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer, today announced multiple presentations on TK-6302 were ...

According to SNS Insider, the global Cell Line Development Market was valued at USD 5.46 billion in 2023 and is projected to reach USD 12.56 billion by 2032, expanding at a CAGR of 9.66% from ...

In any industrial fermentation, the substrate plays a vital role and ir accounts for about 70% of production cost. The ...